tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

HK:2696 Stock Latest News

Shanghai Henlius Begins Phase 2 Clinical Trial for Breast Cancer Treatment
Company AnnouncementsShanghai Henlius Begins Phase 2 Clinical Trial for Breast Cancer Treatment
5d ago
2696
Shanghai Henlius Biotech Announces AGM to Discuss Key Resolutions
PremiumCompany Announcements
Shanghai Henlius Biotech Announces AGM to Discuss Key Resolutions
7d ago
2696
Shanghai Henlius Biotech Begins Clinical Trial for Innovative Cancer Treatment
PremiumCompany Announcements
Shanghai Henlius Biotech Begins Clinical Trial for Innovative Cancer Treatment
13d ago
2696
Shanghai Henlius Biotech’s HLX04-O Achieves Phase 3 Success in wAMD Treatment
PremiumCompany Announcements
Shanghai Henlius Biotech’s HLX04-O Achieves Phase 3 Success in wAMD Treatment
19d ago
2696
Shanghai Henlius Biotech’s HLX11 Biosimilar Gains EMA Validation
PremiumCompany Announcements
Shanghai Henlius Biotech’s HLX11 Biosimilar Gains EMA Validation
25d ago
2696
Shanghai Henlius Advances Phase 3 Trial of HLX22 in Japan
PremiumCompany AnnouncementsShanghai Henlius Advances Phase 3 Trial of HLX22 in Japan
27d ago
2696
Shanghai Henlius Biotech Advances in Autoimmune Treatment with Phase 2 Trial Approval
Premium
Company Announcements
Shanghai Henlius Biotech Advances in Autoimmune Treatment with Phase 2 Trial Approval
27d ago
2696
Shanghai Henlius Biotech Renews Key Procurement Agreements with Fosun High Tech
Premium
Company Announcements
Shanghai Henlius Biotech Renews Key Procurement Agreements with Fosun High Tech
29d ago
2696
Shanghai Henlius Biotech Announces H Share Full Circulation Plan
PremiumCompany Announcements
Shanghai Henlius Biotech Announces H Share Full Circulation Plan
29d ago
2696
Shanghai Henlius Biotech Reports Revenue Growth and Key Drug Approvals in 2024
PremiumCompany Announcements
Shanghai Henlius Biotech Reports Revenue Growth and Key Drug Approvals in 2024
29d ago
2696
Shanghai Henlius Biotech Announces Leadership Changes and Proposed Amendments
PremiumCompany Announcements
Shanghai Henlius Biotech Announces Leadership Changes and Proposed Amendments
29d ago
2696
Shanghai Henlius Biotech Announces Board Composition and Roles
PremiumCompany Announcements
Shanghai Henlius Biotech Announces Board Composition and Roles
29d ago
2696
Shanghai Henlius Biotech’s HLX22 Receives FDA Orphan-drug Designation
PremiumCompany AnnouncementsShanghai Henlius Biotech’s HLX22 Receives FDA Orphan-drug Designation
1M ago
2696
Shanghai Henlius Biotech Schedules Board Meeting to Approve 2024 Financial Results
Premium
Company Announcements
Shanghai Henlius Biotech Schedules Board Meeting to Approve 2024 Financial Results
2M ago
2696
Shanghai Henlius Biotech’s HLX99 Receives FDA Approval for ALS Treatment
Premium
Company Announcements
Shanghai Henlius Biotech’s HLX99 Receives FDA Approval for ALS Treatment
2M ago
2696
Shanghai Henlius Biotech Doses First Patient in Phase 2 HLX43 Trial
PremiumCompany Announcements
Shanghai Henlius Biotech Doses First Patient in Phase 2 HLX43 Trial
2M ago
2696
Shanghai Henlius Signs Licensing Deal with Dr. Reddy’s for Antibody Therapy
PremiumCompany Announcements
Shanghai Henlius Signs Licensing Deal with Dr. Reddy’s for Antibody Therapy
2M ago
2696
Shanghai Henlius Biotech’s HANSIZHUANG Secures EU Approval for Lung Cancer Treatment
PremiumCompany Announcements
Shanghai Henlius Biotech’s HANSIZHUANG Secures EU Approval for Lung Cancer Treatment
3M ago
2696
Shanghai Henlius Biotech Announces New Employee Representative Supervisor
PremiumCompany Announcements
Shanghai Henlius Biotech Announces New Employee Representative Supervisor
3M ago
2696
Shanghai Henlius Biotech’s HLX11 BLA Accepted by FDA
PremiumCompany AnnouncementsShanghai Henlius Biotech’s HLX11 BLA Accepted by FDA
3M ago
2696
Shanghai Henlius Biotech Remains Public as Merger Proposal Fails
Premium
Company Announcements
Shanghai Henlius Biotech Remains Public as Merger Proposal Fails
3M ago
2696
Shanghai Henlius Biotech Confirms Qualification of Joint Company Secretary
Premium
Company Announcements
Shanghai Henlius Biotech Confirms Qualification of Joint Company Secretary
3M ago
2696

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >